Validation of the Chinese Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Alzheimer's Disease and Mild Cognitive Impairment
Authors:
- Gang WangGWGang Wang
- Yue HuangYHYue Huang
- Jun-Peng ZhuangJZJun-Peng Zhuang
- Hui-Dong TangHTHui-Dong Tang
- Ying WangYWYing Wang
- Yu-Lei DengYDYu-Lei Deng
- Wei XuWXWei Xu
- Sheng-Di ChenSCSheng-Di Chen
- Ru-Jing RenRRRu-Jing Ren
- 2 November 2013
- journal article
- research article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 37 (3-4) , 223-231
Abstract
Background/Aims: As a suitable test to screen for Alzheimer's disease (AD) or mild cognitive impairment (MCI), studies to validate the Chinese version of Addenbrooke's Cognitive Examination-Revised (ACE-R) are rare. Methods: A total of 151 subjects were recruited and the neuropsychological assessments were employed. One-way analysis of variance and Bonferroni correction were used to compare scores of different psychometric scales. Intraclass correlation coefficient (ICC) and Cronbach's coefficient α were used to evaluate the reliability of psychometric scales. The validity of ACE-R to screen for mild AD and amnestic subtype of MCI (a-MCI) was assessed by receiver operating characteristic (ROC) curves. Results: The Chinese ACE-R had good reliability (inter-rater ICC = 0.994; test-retest ICC = 0.967) as well as reliable internal consistency (Cronbach's coefficient α = 0.859). With its cutoff of 67/68, the sensitivity (0.920) and specificity (0.857) were lower than for the Mini-Mental State Examination (MMSE) cutoff (sensitivity 1.000 and specificity 0.937) to screen for mild AD. However, the sensitivity of ACE-R to screen for a-MCI was superior to the MMSE with a cutoff of 85/86. The specificity of ACE-R was lower than that of the MMSE to screen for a-MCI. The area under the ROC curve of ACE-R was much larger than that of the MMSE (0.836 and 0.751) for detecting a-MCI rather than mild AD. Conclusion: The Chinese ACE-R is a reliable assessment tool for cognitive impairment. It is more sensitive and accurate in screening for a-MCI rather than for AD compared to the MMSE.Keywords
This publication has 33 references indexed in Scilit:
- Advancing Alzheimer's disease diagnosis, treatment, and care: Recommendations from the Ware Invitational SummitAlzheimer's & Dementia, 2012
- A Systematic Review of Screening Tools for Predicting the Development of DementiaCanadian Journal on Aging / La Revue canadienne du vieillissement, 2012
- A comparison of screening tools for the assessment of Mild Cognitive Impairment: Preliminary findingsNeurocase, 2011
- Mild Cognitive ImpairmentArchives of Neurology, 2009
- Screening for mild cognitive impairment: a systematic reviewInternational Journal of Geriatric Psychiatry, 2009
- A 60-Year-Old Woman With Mild Memory ImpairmentJAMA, 2008
- The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screeningInternational Journal of Geriatric Psychiatry, 2006
- Mild Cognitive Impairment as a Clinical Entity and Treatment TargetArchives of Neurology, 2005
- Mild cognitive impairment as a diagnostic entityJournal of Internal Medicine, 2004
- Mild Cognitive ImpairmentArchives of Neurology, 1999